Return On Equity of Insight Molecular Diagnostics Inc. from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Insight Molecular Diagnostics Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Insight Molecular Diagnostics Inc. Return On Equity for the quarter ending 30 Sep 2025 was 2394%.
  • Insight Molecular Diagnostics Inc. annual Return On Equity for 2024 was -765%, a 851% decline from 2023.
  • Insight Molecular Diagnostics Inc. annual Return On Equity for 2023 was -80%, a 31% increase from 2022.
  • Insight Molecular Diagnostics Inc. annual Return On Equity for 2022 was -116%, a 69% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Insight Molecular Diagnostics Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 2394% +2662% 01 Jul 2025 30 Sep 2025
Q2 2025 -2898% -2739% -1722% 01 Apr 2025 30 Jun 2025
Q1 2025 -767% -624% -437% 01 Jan 2025 31 Mar 2025
Q4 2024 -765% -684% -851% 01 Oct 2024 31 Dec 2024
Q3 2024 -268% -118% -79% 01 Jul 2024 30 Sep 2024
Q2 2024 -159% -35% -29% 01 Apr 2024 30 Jun 2024
Q1 2024 -143% -40% -39% 01 Jan 2024 31 Mar 2024
Q4 2023 -80% +36% +31% 01 Oct 2023 31 Dec 2023
Q3 2023 -149% -59% -65% 01 Jul 2023 30 Sep 2023
Q2 2023 -124% -34% -38% 01 Apr 2023 30 Jun 2023
Q1 2023 -103% -16% -18% 01 Jan 2023 31 Mar 2023
Q4 2022 -116% -47% -69% 01 Oct 2022 31 Dec 2022
Q3 2022 -90% -50% -124% 01 Jul 2022 30 Sep 2022
Q2 2022 -90% -50% -126% 01 Apr 2022 30 Jun 2022
Q1 2022 -87% -38% -78% 01 Jan 2022 31 Mar 2022
Q4 2021 -69% +14% +17% 01 Oct 2021 31 Dec 2021
Q3 2021 -40% +49% +55% 01 Jul 2021 30 Sep 2021
Q2 2021 -40% +48% +55% 01 Apr 2021 30 Jun 2021
Q1 2021 -49% +32% +40% 01 Jan 2021 31 Mar 2021
Q4 2020 -83% -15% -22% 01 Oct 2020 31 Dec 2020
Q3 2020 -89% -16% -23% 01 Jul 2020 30 Sep 2020
Q2 2020 -88% -7% -8.8% 01 Apr 2020 30 Jun 2020
Q1 2020 -81% +32% +29% 01 Jan 2020 31 Mar 2020
Q4 2019 -68% +167% +71% 01 Oct 2019 31 Dec 2019
Q3 2019 -73% +146% +67% 01 Jul 2019 30 Sep 2019
Q2 2019 -81% +190% +70% 01 Apr 2019 30 Jun 2019
Q1 2019 -113% +159% +58% 01 Jan 2019 31 Mar 2019
Q4 2018 -235% +53% +19% 01 Oct 2018 31 Dec 2018
Q3 2018 -219% +10% +4.4% 01 Jul 2018 30 Sep 2018
Q2 2018 -270% -117% -76% 01 Apr 2018 30 Jun 2018
Q1 2018 -272% -128% -88% 01 Jan 2018 31 Mar 2018
Q4 2017 -289% -157% -119% 01 Oct 2017 31 Dec 2017
Q3 2017 -229% -94% -70% 01 Jul 2017 30 Sep 2017
Q2 2017 -154% 01 Apr 2017 30 Jun 2017
Q1 2017 -145% 01 Jan 2017 31 Mar 2017
Q4 2016 -132% 01 Oct 2016 31 Dec 2016
Q3 2016 -135% 01 Jul 2016 30 Sep 2016

Insight Molecular Diagnostics Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -765% -684% -851% 01 Jan 2024 31 Dec 2024
2023 -80% +36% +31% 01 Jan 2023 31 Dec 2023
2022 -116% -47% -69% 01 Jan 2022 31 Dec 2022
2021 -69% +14% +17% 01 Jan 2021 31 Dec 2021
2020 -83% -15% -22% 01 Jan 2020 31 Dec 2020
2019 -68% +167% +71% 01 Jan 2019 31 Dec 2019
2018 -235% +53% +19% 01 Jan 2018 31 Dec 2018
2017 -289% -157% -119% 01 Jan 2017 31 Dec 2017
2016 -132% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.